Malin Deon | Investor Relations |
Rich Murray | Chief Executive Officer and President |
Elizabeth Trehu | Chief Medical Officer |
Kim Drapkin | Chief Financial Officer |
Mike Ulz | Baird |
Gavin Weiss | JPMorgan |
Steve Seedhouse | Raymond James |
Arthur He | H.C. Wainwright |
Zegbeh Jallah | ROTH Capital Markets |
Jim Birchenough | Wells Fargo Securities |
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics Third Quarter 2020 Earnings Conference Call. Currently, all participants are in a listen-only mode. [Operator Instructions] I will now turn the call over to your host, Malin Deon with Jounce Therapeutics. Please go ahead.
Thank you, operator.